Skip to main content

Study Design and End Points in Ankylosing Spondylitis Clinical Trials

  • Chapter
Clinical Trials in Rheumatoid Arthritis and Osteoarthritis

Part of the book series: Clinical Trials ((CLINICAL))

  • 1224 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. Dougados M, Gueguen A, Nakache JP, Velicitat P, Veys EM, Zeidler H, Calin A. Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial. Rheumatology 1999;38(3):235–244.

    Article  PubMed  CAS  Google Scholar 

  2. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27(4):361–368.

    Article  PubMed  Google Scholar 

  3. van der Heijde D, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden S. Preliminary core sets for endpoints in ankylosing spondylitis. Assessment in Ankylosing Spondylitis Working Group. J Rheumatol 1997;24(11):2225–2229.

    PubMed  Google Scholar 

  4. van der Heijde D, Calin A, Dougados M, Khan MA, van der Linden S, Bellamy N. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group Assessment in Ankylosing Spondylitis. J Rheumatol 1999;26(4): 951–954.

    PubMed  Google Scholar 

  5. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21(12):2286–2291.

    PubMed  CAS  Google Scholar 

  6. Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21(12):2281–2285.

    PubMed  CAS  Google Scholar 

  7. Dougados M, Gueguen A, Nakache JP, Nguyen M, Amor B. Evaluation of a functional index for patients with ankylosing spondylitis. J Rheumatol 1990;17(9):1254–1255.

    PubMed  CAS  Google Scholar 

  8. Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT. Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS). Br J Rheumatol 1996;35(4):373–376.

    Article  PubMed  CAS  Google Scholar 

  9. Creemers MCW, van’t Hof MA, Gribnau FWJ, van de Putte LBA, van Riel PLCM. A radiographic scoring system and identification of variables measuring structural damage in ankylosing spondylitis. Thesis, University of Nijmegen, The Netherlands; 1993.

    Google Scholar 

  10. Kennedy LG, Jenkinson TR, Mallorie PA, Whitelock HC, Garrett SL, Calin A. Ankylosing spondylitis: the correlation between a new metrology score and radiology. Br J Rheumatol 1995;34(8):767–770.

    Article  PubMed  CAS  Google Scholar 

  11. Wanders A, Landewé R, Spoorenberg A, et al. What is the most appropriate radiologic scoring method for Ankylosing Spondylitis? A comparison of the available methods based on the outcome measures in rheumatology clinical trials filter. Arthritis Rheum 2004;50(8):2622–2632.

    Article  PubMed  Google Scholar 

  12. Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 2001;44(8):1876–1886.

    Article  PubMed  CAS  Google Scholar 

  13. Brandt J, Listing J, Sieper J, Rudwaleit M, van der Heijde D, Braun J. Development and preselection of criteria for short-term improvement after anti-TNFα therapy in ankylosing spondylitis. Ann Rheum Dis 2004;63(11):1438–1444.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

van der Heijde, D. (2008). Study Design and End Points in Ankylosing Spondylitis Clinical Trials. In: Reid, D.M., Miller, C.G. (eds) Clinical Trials in Rheumatoid Arthritis and Osteoarthritis. Clinical Trials. Springer, London. https://doi.org/10.1007/978-1-84628-742-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-742-8_5

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-874-9

  • Online ISBN: 978-1-84628-742-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics